Researchers in France and Japan have transmitted what they describe as the first DNA-encrypted message between laboratories, ...

A collaborative research study co-led by scientists at the Icahn School of Medicine at Mount Sinai and the Liber Institute ...

DelveInsight’s, “Hepatic Tumor Pipeline Insight 2026” report provides comprehensive insights about 75+ companies and ...

ProQR Therapeutics N.V. (Nasdaq: PRQR) (ProQR), a company dedicated to changing lives through transformative RNA therapies based on its proprietary Axiomer™ RNA editing technology platform, today ...

Researchers have identified a promising antiviral compound that blocks hepatitis E replication in early studies. Because it ...

Countless scientists and at least a dozen high-concept sci-fi comedies over the past 30 years have speculated on the ...

A drug that is already in clinical trials against hepatitis C virus can also prevent hepatitis E virus from replicating.

A research team from The Hong Kong University of Science and Technology (HKUST) has made an advance in understanding the molecular machinery of RNA silencing. The team uncovered how the human enzyme ...

Plant immunity is largely initiated at the cellular level, with each cell capable of autonomous detection and response, while also coordinating systemic signaling across the organism—unlike the ...

Around 70,000 people die each year from infections with the hepatitis E virus. There is currently neither a vaccine nor a specific drug against this ...

Attorneys for Florida death row inmate James Aren Duckett filed an emergency motion with the Florida Supreme Court late ...

Previously discovered large RNA polymerase ribozyme structure (grey, based on pdb: 8T2P) vs. newly discovered small RNA polymerase ribozyme QT45 (blue, AlphaFold3 prediction). Credit: MRC Laboratory ...